199 related articles for article (PubMed ID: 37325244)
21. Microarray patch for HIV prevention and as a multipurpose prevention technology to prevent HIV and unplanned pregnancy: an assessment of potential acceptability, usability, and programmatic fit in Kenya.
Gachigua SG; Karuga R; Ngunjiri A; Jarrahian C; Coffey PS; Kilbourne-Brook M; Otiso L
Front Reprod Health; 2023; 5():1125159. PubMed ID: 37168102
[TBL] [Abstract][Full Text] [Related]
22. Two Birds with One Stone: Health Care Providers' Perspectives about Prevention Technologies in Kenya and South Africa.
Lutnick A; Shapley-Quinn MK; Manenzhe KN; Onyango J; Agot K; Ahmed K; van der Straten A
J Int Assoc Provid AIDS Care; 2019; 18():2325958219841366. PubMed ID: 31018754
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis.
Milali MP; Resar D; Kaftan D; Campbell J; Olowu A; Edwards D; Platais I; Kim HY; Jenkins S; Bershteyn A
Front Reprod Health; 2023; 5():1144217. PubMed ID: 37266447
[TBL] [Abstract][Full Text] [Related]
24. Equipping providers to offer novel MPTs: Developing counseling messages for the Dual Prevention Pill in clinical studies and beyond.
Segal K; Harris DM; Carmone A; Haddad LB; Hadigal S; Hatzold K; Jones C; Lathrop E; Mason J; Mikulich M
Front Reprod Health; 2023; 5():1155948. PubMed ID: 37284490
[TBL] [Abstract][Full Text] [Related]
25. Prioritizing multipurpose prevention technology development and investments using a target product profile.
Romano J; Manning J; Hemmerling A; McGrory E; Holt BY
Antiviral Res; 2013 Dec; 100 Suppl():S32-8. PubMed ID: 24188707
[TBL] [Abstract][Full Text] [Related]
26. [Current status of the female condom in Africa].
Deniaud F
Sante; 1997; 7(6):405-15. PubMed ID: 9503499
[TBL] [Abstract][Full Text] [Related]
27. Interest in multipurpose prevention of HIV and pregnancy: perspectives of women, men, health professionals and community stakeholders in two vaginal gel studies in southern Africa.
Woodsong C; Musara P; Chandipwisa A; Montgomery E; Alleman P; Chirenje M; Chipato T; Martinson F; Hoffman I
BJOG; 2014 Oct; 121 Suppl 5():45-52. PubMed ID: 25335840
[TBL] [Abstract][Full Text] [Related]
28. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States.
Hynes JS; Sales JM; Sheth AN; Lathrop E; Haddad LB
Contraception; 2018 Mar; 97(3):277-284. PubMed ID: 29055782
[TBL] [Abstract][Full Text] [Related]
29. Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability.
Shapley-Quinn MK; Song M; Chen BA; Devlin B; Luecke E; Brown J; Blithe DL; Achilles SL; van der Straten A
Front Reprod Health; 2023; 5():1147628. PubMed ID: 37484873
[TBL] [Abstract][Full Text] [Related]
30. The Promise of the Dual Prevention Pill: A Framework for Development and Introduction.
Friedland BA; Mathur S; Haddad LB
Front Reprod Health; 2021 Jun; 3():. PubMed ID: 34318291
[TBL] [Abstract][Full Text] [Related]
31. Strategic actions to advance multipurpose prevention technologies in low- and middle-income countries.
Young Holt B; van der Straten A; Barker T; Chirenje ZM; Cameron AI; Scott C; Casas CP; Romano J
Front Reprod Health; 2023; 5():1150857. PubMed ID: 37465533
[TBL] [Abstract][Full Text] [Related]
32. Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe.
Minnis AM; Etima J; Musara P; Browne EN; Mutero P; Kemigisha D; Mgodi NM; Nakabiito C; Shapley-Quinn MK; Stoner MCD; Hartmann M; Macagna N; Piper J; van der Straten A
AIDS Behav; 2022 Dec; 26(12):3848-3861. PubMed ID: 35674885
[TBL] [Abstract][Full Text] [Related]
33. Women Want Choices: Opinions from the Share.Learn.Shape Global Internet Survey About Multipurpose Prevention Technology (MPT) Products in Development.
Friedland BA; Plagianos M; Savel C; Kallianes V; Martinez C; Begg L; Guthrie KM; Venkatasetty D; Pickett J; Haddad LB
AIDS Behav; 2023 Jul; 27(7):2190-2204. PubMed ID: 36881183
[TBL] [Abstract][Full Text] [Related]
34. Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products.
Minnis AM; Montgomery ET; Napierala S; Browne EN; van der Straten A
J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 3():S222-S229. PubMed ID: 31764258
[TBL] [Abstract][Full Text] [Related]
35. Beyond HIV microbicides: multipurpose prevention technology products.
Malcolm RK; Boyd P; McCoy CF; Murphy DJ
BJOG; 2014 Oct; 121 Suppl 5():62-9. PubMed ID: 25335842
[TBL] [Abstract][Full Text] [Related]
36. Engaging study participants in interpreting results: lessons from the TRIO study in Kenya and South Africa.
Agot K; Minnis AM; Manenzhe K; Browne EN; Ahmed K; Okello T; van der Straten A
Int J Womens Health; 2019; 11():395-403. PubMed ID: 31372060
[No Abstract] [Full Text] [Related]
37. How might we motivate uptake of the Dual Prevention Pill? Findings from human-centered design research with potential end users, male partners, and healthcare providers.
Nyagah W; Segal K; Feltham J; Ash A; Major J; Masani M
Front Reprod Health; 2023; 5():1254953. PubMed ID: 38023531
[TBL] [Abstract][Full Text] [Related]
38. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
39. A strategic action framework for multipurpose prevention technologies combining contraceptive hormones and antiretroviral drugs to prevent pregnancy and HIV.
Young Holt B; Dellplain L; Creinin MD; Peine KJ; Romano J; Hemmerling A
Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):326-334. PubMed ID: 30247084
[TBL] [Abstract][Full Text] [Related]
40. Vaginal multipurpose prevention technologies: promising approaches for enhancing women's sexual and reproductive health.
Fernandes T; Baxi K; Sawarkar S; Sarmento B; das Neves J
Expert Opin Drug Deliv; 2020 Mar; 17(3):379-393. PubMed ID: 32036727
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]